等待開盤 05-20 09:30:00 美东时间
+0.290
+7.84%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据AmpliTech业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 2026年第一季度营收达到535万美元,同比增长48.6%(2025年同期为360万美元) **盈利能力:** 毛利润257万美元,同比大幅增长116.1%(2025年同期为119万美元);毛利率显著改善至48%,较上年同期的33%提升15个百分点 **净亏损:** 净亏损152万美元,同比改善17.3%,亏损幅度收窄 **现金状况:** 截至2026年3月31日,现金、现金等价物及有价证券余额为1,840万美元 ## 2. 财务指标变化 **营运资
05-15 12:15
AmpliTech Group (($AMPG)) has held its Q1 earnings call. Read on for the main h...
05-15 08:44
Shares of stocks within the broader tech sector are trading higher amid possibl...
05-15 03:52
Amplitech Group press release (AMPG): Q1 Revenue of $5.35M (+48.6% Y/Y) beats by $0.35M. Gross profit increased 116.1% year-over-year to $2.57 million from $1.19 million in the prior- year period. Net...
05-14 04:20
AmpliTech Gr (NASDAQ:AMPG) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 33.33 percent increase over losses of $(0.09) per share from the
05-14 04:09
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
These orders reflect incremental demand, including additional quantities beyond those initially contemplated, driven by ongoing requirements for the radio configuration currently being delivered during the Company's
04-28 20:03
AmpliTech Group announced receipt of follow-on orders exceeding $2 million under a previously disclosed Letter of Intent with a North American mobile network operator. These orders reflect incremental demand for the company's radio configuration, with deliveries expected into fiscal year 2026. From January through April 2026, the company has recorded bookings exceeding $8 million, bringing total backlog to over $20 million. CEO Fawad Maqbool high...
04-28 12:00
AmpliTech Group (($AMPG)) has held its Q4 earnings call. Read on for the main h...
04-11 08:02
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30